MOLBIO DIAGNOSTICS Latest Share Price (MOLBIO)
TODAY IN ONE LINE
MOLBIO edged up 0.9%, in line with Nifty's 0.0% move.
With a market cap of ₹15,215.14 Cr., it trades at a P/E of N/A. Track live valuations, technical indicators, and peers comparison below. Check delivery conviction and recent filings to build your view.
How good is this company?
Overall performance across 5 key dimensions.
MOLBIO DIAGNOSTICS flags & news
Key strengths, potential risks, and recent updates.
Green Flags
- ●Virtually Debt-FreeVery low Debt-to-Equity of 0.00x
- ●Zero Pledge RiskNo recent active promoter pledging found
Red Flags
- ●Sales ContractionQuarterly sales dropped 2.2% YoY
Latest MOLBIO DIAGNOSTICS News
What changed recently?
Recent events, corporate actions, and announcements.
MOLBIO DIAGNOSTICS valuation: P/E, P/B and sector benchmarks.
Twelve years of multiples investors have paid for MOLBIO DIAGNOSTICS, framed against the sector median so the premium or discount is obvious at a glance.
Market-priced ratios use the latest available quote; accounting metrics use the latest reported filing. Compare values with matched peers and the company's own history.
Valuation
Profitability
Growth
Financial Health
MOLBIO DIAGNOSTICS technical analysis: indicators, pivots and CPR.
Latest RSI, MACD and moving-average signals plus the latest pivot and Central Pivot Range levels for MOLBIO DIAGNOSTICS — derived from the latest tape, not yesterday's close.
MOLBIO DIAGNOSTICS last traded at ₹1,319 with an intraday range of ₹1,291–₹1,382 — latest indicator, pivot and CPR signals below.
Pivot points
Standard pivot — most widely referenced.
Pivot levels · Classic
Last: ₹1319.00| Level | Price (₹) | Distance | % Δ |
|---|---|---|---|
| R4 | 1552.33 | +233.33 | +17.69% |
| R3 | 1461.33 | +142.33 | +10.79% |
| R2 | 1421.67 | +102.67 | +7.78% |
| R1 | 1370.33 | +51.33 | +3.89% |
| PIVOT | 1330.67 | 11.67 | 0.88% |
| CURRENT | 1319.00 | — | — |
| S1 | 1279.33 | -39.67 | -3.01% |
| S2 | 1239.67 | -79.33 | -6.01% |
| S3 | 1188.33 | -130.67 | -9.91% |
| S4 | 1097.33 | -221.67 | -16.81% |
MOLBIO is trading Below CPR, indicating Bearishness
CPR is Wider, suggesting unlikely for trending moves
Day's range: ₹1291–₹1368.9
Trading Inside opening range
MOLBIO DIAGNOSTICS financials: P&L, balance sheet, cash flow, ratios.
Reported annual and quarterly results for MOLBIO DIAGNOSTICS — consolidated or standalone — with margins, YoY growth and key ratios inline.
MOLBIO DIAGNOSTICS reports its full P&L, balance sheet, cash flow and ratios on this page — current market capitalisation of ₹15,215.14 Cr. and reported EPS of ₹4.91.
MOLBIO DIAGNOSTICS segment analysis : revenue and profit mix.
Disclosed business segments at MOLBIO DIAGNOSTICS with their share of revenue and profit, switchable between consolidated and standalone reporting.
MOLBIO DIAGNOSTICS discloses revenue and profit across multiple business segments — toggle between consolidated and standalone views to see the mix.
Segment-wise Financial Analysis
The Bull, Bear, and Flip case for MOLBIO DIAGNOSTICS.
Our AI distills the core fundamental drivers supporting MOLBIO DIAGNOSTICS, the risks that threaten it, and the quantitative conditions that could weaken the thesis.
What you're getting.
No strengths or opportunities on record.
Key Risks.
No weaknesses or threats on record.
Flip Conditions.
Reassess if quarterly profit growth turns negative for two consecutive quarters. The bull case relies on compounding earnings.
MOLBIO DIAGNOSTICS peer comparison — same-sector benchmarks.
Same-sector listed peers ranked on P/E, market cap, dividend yield and growth — MOLBIO DIAGNOSTICS is highlighted for quick read-across.
Quick Compare
Peer Comparison
| Company Name |
|---|
MOLBIO DIAGNOSTICS chart patterns: breakouts, tops and bottoms.
Auto-detected classical chart patterns for MOLBIO DIAGNOSTICS — Double Top/Bottom, Head & Shoulders, Triple Bottom and more — with break levels, targets and quality scores across Intraday, Daily and Weekly timeframes.
MOLBIO DIAGNOSTICS delivery volume — last 20 sessions of conviction.
Daily traded volume and delivery percentage for MOLBIO DIAGNOSTICS over 20 sessions — the gap between intraday flipping and genuine accumulation.
Latest session delivery in MOLBIO DIAGNOSTICS stood at 7.2% of traded volume, against a 20-day average of 15.7%.
MOLBIO DIAGNOSTICS announcements: results, concalls, ratings, M&A.
Filings MOLBIO DIAGNOSTICS sent to the exchanges, sequenced as they hit the tape — concall transcripts, results, credit ratings and presentations.
MOLBIO DIAGNOSTICS files concall transcripts, results, credit ratings and corporate-action notices on the NSE and BSE exchange portals — latest 10 documents below.
Analysts/Institutional Investor Meet/Con. Call Updates
Molbio Diagnostics Limited has informed the Exchange about Transcript of the Earnings Call held on September 08, 2026 in relation to the Unaudited…
Updates
Molbio Diagnostics Limited has informed the Exchange regarding Intimation regarding change of Corporate Identification Number (CIN) of the Company.
Analysts/Institutional Investor Meet/Con. Call Updates
Molbio Diagnostics Limited has informed the Exchange about Link of Recording
General Updates
Molbio Diagnostics Limited has informed the Exchange about Investor Presentation on the Unaudited Financial Results (Standalone & Consolidated) for…
Copy of Newspaper Publication
Molbio Diagnostics Limited has informed the Exchange about Copy of Newspaper Publication of Un-audited Financial Results for the quarter ended June…
Investor decks & rating reports.
MOLBIO DIAGNOSTICS dividend history, splits and bonus issues.
Every dividend, stock split and bonus issue MOLBIO DIAGNOSTICS has declared, sequenced by announce and record date.
MOLBIO DIAGNOSTICS corporate-action history below covers all declared dividends, stock splits and bonus issues recorded with NSE and BSE.
About MOLBIO DIAGNOSTICS: business, sector, key facts.
What MOLBIO DIAGNOSTICS does, where it operates, the people running it, and the numbers that describe the entity behind the ticker.
MOLBIO DIAGNOSTICS is a listed Indian equity.
MOLBIO DIAGNOSTICS
Related
Peers, sector trends, screeners and strategy playbooks contextual to this stock.
- 3B BLACKBIO DX (3BBLACKBIO) Share PricePeer
- ABBOTT INDIA (ABBOTINDIA) Share PricePeer
- ACUTAAS CHEMICALS (ACUTAAS) Share PricePeer
- ANLON HEALTHCARE (AHCL) Share PricePeer
- AMANTA (AMANTA) Share PricePeer
- Top Gainers TodayScreener
- EMA Crossover ScreenerScreener
- Stock Quality ScorecardScreener
- Technical DashboardScreener
- Results CalendarScreener
- FII Buying ActivityScreener
- All Technical ScreenersScreener
- All Trading StrategiesStrategy
Questions investors ask about MOLBIO DIAGNOSTICS (MOLBIO).
Quick answers grounded in this page's data — price action, fundamentals, ratios and ownership.
01What is the current share price of MOLBIO DIAGNOSTICS (MOLBIO)?
The current share price of MOLBIO DIAGNOSTICS (MOLBIO) is ₹1,319.00. Today, the stock has gained by ₹12.00 (0.92%), trading in a range of ₹1,291.00 to ₹1,382.00. The stock opened at ₹1,313.50 with a trading volume of 23,14,434 shares.
02What is the 52-week high and low price of MOLBIO DIAGNOSTICS stock?
The 52-week high price of MOLBIO DIAGNOSTICS (MOLBIO) is ₹1,686.80, while the 52-week low is ₹926.35. Currently trading at ₹1,319.00, the stock is 42.39% above its 52-week low and 21.8% below its 52-week high. These levels help investors understand the stock's price volatility and trading range over the past year.
03What is the dividend yield of MOLBIO DIAGNOSTICS and when is the next dividend?
MOLBIO DIAGNOSTICS offers a dividend yield of 0%, which means for every ₹100 invested at the current price of ₹1,319.00, you can expect to receive approximately ₹0.00 annually as dividends. The face value of the stock is ₹0.00. For information about the next dividend announcement and ex-dividend date, please check the company's official announcements or visit the BSE/NSE websites.
04How is MOLBIO DIAGNOSTICS stock performing today in the market?
MOLBIO DIAGNOSTICS stock opened at ₹1,313.50 and is currently trading at ₹1,319.00, showing a gain of ₹12.00 (0.92%). The intraday high is ₹1,382.00 and low is ₹1,291.00. The trading volume stands at 23,14,434 shares, indicating strong market participation today.
05What is the market capitalization of MOLBIO DIAGNOSTICS?
MOLBIO DIAGNOSTICS has a market capitalization of ₹15,215.14 Cr., making it a small-cap company. Market cap is calculated by multiplying the current stock price (₹1,319.00) by the total number of outstanding shares. This metric helps investors understand the company's size, stability, and investment risk profile.
06What is the ROE and ROCE of MOLBIO DIAGNOSTICS?
MOLBIO DIAGNOSTICS has a Return on Equity (ROE) of 0% and Return on Capital Employed (ROCE) of 0%. ROE measures how efficiently the company generates profits from shareholders' equity, while ROCE indicates how well the company uses its capital to generate profits. These returns may need improvement for better profitability. Higher percentages generally indicate better financial performance.
07Which sector and industry does MOLBIO DIAGNOSTICS belong to?
MOLBIO DIAGNOSTICS operates in the broader sector and belongs to the its industry. The company competes with other players in this space and its performance is influenced by sector-specific trends, regulatory changes, and market dynamics. Understanding the sector helps investors assess growth potential, cyclical patterns, and industry-specific risks that may impact the stock's performance.
08What is the sales and profit growth of MOLBIO DIAGNOSTICS?
MOLBIO DIAGNOSTICS has reported a sales growth of 0% and profit growth of 7.36%. The company may be facing growth challenges or operating in a mature market. Consistent growth over multiple quarters is a positive indicator for long-term investors. Compare these growth rates with industry peers for better perspective.
The data, ratios and commentary about MOLBIO DIAGNOSTICS (MOLBIO) on this page are published for educational and informational purposes only and are not investment, legal or tax advice. StockeZee is not a SEBI-registered investment adviser, research analyst or portfolio manager, and no content here should be construed as a recommendation to buy, hold or sell any security. Live and historical market data may be delayed, revised by the exchanges, or contain errors; figures sourced from third-party feeds and corporate disclosures may not always be current. Past performance is not indicative of future results, and equity investments carry the risk of capital loss. Before acting on anything you read here, please consult a SEBI-registered financial advisor and read all scheme-related documents carefully.